ranibizumab |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : agerelated amd angiogenesis antiangiogenic antibody antivegf bevacizumab biological biosimilar biotech biotechnology degeneration disease drug fab humour immunoglobulin immunology infusion injection inn intravitreal intravitreally mab macular monoclonal nomenclature peptide protein ranibizumab vitreous wet |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Ranibizumab monoclonal antibody fragment (Fab) drug. Targets Vascular endothelial growth factor A (VEGFA) and is indicated for the treatment of age-related macular degeneration (AMD). Closely related to bevacizumab. Generic name and stylized antibody representation |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||